Spine Aesculap Implant Systems Announces the Long-Term Reporting from its Pivotal IDE Trial for the activL® Artificial Disc byChris StewartJuly 26, 2021
Spine Aesculap Implant Systems Announces New Positive Third-Party Clinical Guidelines that May Introduce Access for More than 8.5 Million Commercially Insured Americans to the activL® Artificial Disc byChris StewartJuly 7, 2020
